Liver cancer in children is rare, but when it occurs, the two main types are hepatoblastoma (HB) and hepatocellular carcinoma ...
Gyre Therapeutics, Inc. (Gyre or Gyre Therapeutics) (Nasdaq: GYRE), a San Diego-based innovative commercial stage ...
In a recent article, Sanofi presented preclinical data for an in vivo CAR-T platform that reengineers T cells directly within ...
Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and ...
India, March 17 -- Can the human body produce vitamin B2? No, the human body cannot produce vitamin B2 (riboflavin) on its own. Without enough riboflavin, the body cannot make the molecules needed to ...
International experts call for research, monitoring, and public awareness on micro- and nanoplastic pollution BRUSSELS, March 17, 2026 /PRNewswire/ -- On February 24, 2026, the European Parliament ...
AstraZeneca’s Imfinzi in combo with standard-of-care FLOT chemotherapy gets European approval to treat patients with early gastric and gastroesophageal cancers: Cambridge, UK Tu ...
16h
ALLATRA Global Research Center: European Parliament Hosts Conference on Global Nanoplastics Risks
International experts call for research, monitoring, and public awareness on micro- and nanoplastic pollutionBRUSSELS, March ...
Metabolic syndrome (MetS) is a multifaceted disorder characterized by a constellation of metabolic abnormalities, including central obesity, dyslipidemia, ...
18h
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
Detailed price information for Bridgebio Oncology Therapeutics Inc (BBOT-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results